2021
DOI: 10.1016/j.bmc.2021.116349
|View full text |Cite
|
Sign up to set email alerts
|

Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(30 citation statements)
references
References 53 publications
(73 reference statements)
0
17
0
Order By: Relevance
“…At the other end of the molecule, methylsulfonylpiperazine moiety interacts with Phe192 via π–sulfur contact. The results from molecular docking studies suggest that the potential inhibitory activity is a non-redox mechanism and competes with a substrate to bind the active site [ 28 , 49 , 50 , 51 , 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…At the other end of the molecule, methylsulfonylpiperazine moiety interacts with Phe192 via π–sulfur contact. The results from molecular docking studies suggest that the potential inhibitory activity is a non-redox mechanism and competes with a substrate to bind the active site [ 28 , 49 , 50 , 51 , 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…Deuterated, pepsin-digested samples of h12-LOX were analyzed using a 1200 series LC system (Agilent, Santa Clara, CA) that was connected in-line with the LTQ Orbitrap XL mass spectrometer (Thermo), as described by our laboratory previously [ 19 , 29 ]. Mass spectral data corresponding to the HDX measurements were analyzed using HDX Workbench [ 30 ].…”
Section: Methodsmentioning
confidence: 99%
“…The only inhibitors known to date that specifically inhibit ALOX15B with micromolar potency were synthesized based on the concept of a U-shaped substrate binding cavity ( Jameson et al, 2014 ; Tsai et al, 2021a ). The respective inhibitors (MLS000327069, MLS000327186, and MLS000327206) are described to have a 50-fold higher selectivity for ALOX15B versus human ALOX5, ALOX12, ALOX15, cyclooxygenase (COX)-1 and COX-2, without affecting redox activity ( Tsai et al, 2021a ). Besides recombinant enzyme preparations, inhibition of ALOX15B was studied in a cell assay that used ALOX15B-overexpressing HEK293T cells.…”
Section: Inhibition Of Alox15bmentioning
confidence: 99%